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Equipment for the Biopsy:

Introduction:
• Magnetic Resonance Imaging (MRI) creates crosssectional images of the body. MRI does not use
ionizing radiation. The images are created by
magnetic fields and radiofrequencies reacting with
biologic tissues.
• “MRI is able to distinguish very small differences in
contrast among tissues by manipulating biologic
tissue with magnetic fields and radio waves.” MRI’s
ability to distinguish contrast between tissues makes
it a top modality to image the breast.
(Long, Rollins, & Smith, 2019, p. 246)

Breast MRI:

• Breast Coil
• Medial and lateral paddles for compression
• Fiducial markers to identify the outer portion of the
breast
• Sterile tray: two syringes with lidocaine, two
syringes with lidocaine and epinephrine, gauze pads,
scalpel, and grid
• Localization device: small grid, introducer including
plastic sheath with numeric grading, metallic stylist,
and blunt tip plastic introducer, vacuum-assisted
breast biopsy (VABB) apparatus and needle, and
localization marker clip
(Papalouka et al., 2018, pp. 908e19-21)

• Should be performed on days 3 through 14 of the 28day menstrual cycle.

Figure 2. Components of MRI-compatible coaxial system (Gao et al., 2020,
p.4676)

• The images are taken on 1.5T or 3T magnetic field
strength machines. The patient is prone with breast
pendent in the breast coil.

Case Study:

Disadvantages

• This case study follows a 62-year-old women with
known primary Non-Hodgkin's Lymphoma.

•

The lesion may not enhance during the biopsy
resulting in the study being canceled.

• In November of 2016, the patient had an MRI of the
breast that indicated a 13 mm lesion in her upper left
breast. A needle biopsy revealed a proliferation of
small atypical lymphocytes with a diffuse growth
pattern and small eosinophils.

•

The risk of rupture of implants.

•

Cancer detection, false-negative, and
underestimation rates vary among previously
published studies using MR-guided vacuumassisted breast biopsy. (Spick et. al., 2016, p. 3908)

• The patient was started on chemotherapy followed
by radiotherapy treatments localized to the left
breast. No significant uptake was found, and the
patient was diagnosed in remission.

New Technology in MRI-Guided Breast
Biopsy:

• In 2018, a breast MRI demonstrated a non-mass
enhancement measuring 33mm that was not
demonstrated on ultrasound or mammography.

• Contrast media is needed to enhance any lesions on
the images. The most common sequences are T2 fatsuppressed, pre-contrast T1 no-fat-suppressed, precontrast T1 fat-suppressed, and post contrast T1
images.
• All breast images are read using the breast imaging
reporting and data system or BI-RADS.

(Gao et al., 2020, pp. 4672-4673)

Figure 1. Unenhanced T-2 weighted image (Papalouka et al., 2018, p. 908e23)

Indications and Contraindications:
Indications
• Lesions found on imaging identified as BIRAD 3, 4,
or 5 would indicate a breast biopsy.
Contradictions
• Include claustrophobia, metallic implants that are
not MRI safe, and individuals allergic to contrast
media. Patients with deranged clotting function,
anticoagulation, when the target lesion cannot be
reidentified on pre biopsy images, and not being able
to access the lesion.
(Papalouka, Kilburn-Toppin, Gaskarth, & Gilbert, 2018, p. 908e18)

•

MRI is always changing which requires equipment
that evolves with it. Imaging sequences are being
developed using diffusion-weighted imaging to
eliminate the use of contrast media. Other
researchers are developing an MR-compatible
needle intervention robotic system that can
approach tumors from the side with a bendable
needle to allow better access. Other researchers are
developing a coil to have the patient supine rather
than prone on the MR table. (Gao et al., 2020, p. 4679)

MRI-Guided Breast Biopsy Procedure:
• An IV is started. The patient is prone with breasts
pendent in the coil. Compression is applied with grid
fixed to the breast affected. The patient is imaged to
relocate the lesion.
• Axial T1-weighted 3D fat-saturated images are taken
to relocate the lesion. Then the contrast is injected
and post contrast dynamic T1 3D fat-saturated
images are taken. The images are reviewed by the
technologist and the radiologist to measure the
location in the grid of the lesion. Once the lesion is
located, the biopsy can be performed.
• The radiologist confirms the lesion placement within
the grid and numbs the breast. The localizer is
placed in the breast and the patient is put back into
the machine to confirm the localizer is in the region.
• The biopsy begins and the VABB apparatus is
inserted into the localizer. The radiologist will turn
the VABB apparatus clockwise around the lesion
collecting 10 samples from the breast. The VABB
apparatus is removed, and a marker clip is placed in
the breast to confirm the site of the biopsy on future
imaging.
• A final image is taken in the MRI to confirm clip
placement. Then the patient receives a same day soft
compression mammogram. (Papalouka et al., 2018, p. 908e21)

Figure 3. Case study breast (Meucci et al., 2021, p. 929309-3)

• Since the lesion was only identified on MRI, an
MRI-guided breast biopsy was scheduled. The
biopsy was accessed with an 8-gauge VAB with
lateral access to the breast in 30 minutes time.
Twelve samples were taken. The results of her
biopsy revealed the patient had ductal carcinoma insitu. Two-weeks later the patient underwent a lower
external quadrantectomy of the breast on the lesion.
The tumor was completely removed, and the patient
was discharged in good health. (Meucci et al., 2021, pp. 2-5)

Advantages and Disadvantages of MRIGuided Breast Biopsy:
Advantages
•

The procedure requires the use of contrast media to
enhance lesions resulting in better visualization and
higher sensitivity than other modalities for imaging
of the breast. (Gao et al., 2020, p. 4679)

•

“It has been shown that MR-guided vacuumassisted breast biopsies (VABB) are a fast, safe, and
accurate method that cause only minimal scarring
and no consecutive breast deformity compared to
surgical breast biopsy” (Spick et. al., 2016, p. 3908)

Figure 4. MRI-guided biopsy position (Gao et al., 2020, p. 4674)

Conclusion:
• MRI provides high visualization of breast lesions
and is used along with mammography and
ultrasound to detect and monitor lesions. If a lesion
is only visualized on MRI, it would indicate the
lesion needs be biopsied. MRI requires the use of the
breast coil and biopsy equipment including a grid
and VABB apparatus. The lesions are located by
experienced breast radiologists and MR
technologists. Once the lesion is targeted on quick
prebiopsy breast scans, the biopsy is commenced.
Following the biopsy, the patient receives a soft
compression mammogram. The patient will also
have follow-up imaging six months later. MRI gives
patients superior imaging and allows for better
visualization of lesions.
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